Showing results (551-560 of 684) with videos related to

Sort By:
Pageof 69
Hepatology Communications|February 7, 2018
Hepatitis E virus replication and interferon responses in human placental cellsLeonard Knegendorf, Svenja A Drave, Viet Loan Dao Thi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2022
A ribavirin-induced ORF2 single-nucleotide variant produces defective hepatitis E virus particles with immune decoy functionToni Luise Meister, Yannick Brüggemann, Maximilian K Nocke, et al.
Antiviral Research|July 30, 2023
Janus kinase-inhibition modulates hepatitis E virus infectionVolker Kinast, Ioana Andreica, Gerrit Ahrenstorf, et al.
Journal of Hepatology|April 16, 2020
C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelleVolker Kinast, Agnieszka Plociennikowska, Anggakusuma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2021
Design of Multidrug-Resistant Tuberculosis Treatment Regimens Based on DNA SequencingHans-Peter Grobbel, Matthias Merker, Niklas Köhler, et al.
Archives of Pathology & Laboratory Medicine|September 2, 2025
QuANTUM-First: Clinical Validation of the LeukoStrat Companion Diagnostic for the Selection of Patients With Acute Myeloid Leukemia Harboring FMS-Like Tyrosine Kinase 3-Internal Tandem Duplications for Treatment With QuizartinibJaime E Connolly Rohrbach, Ken C N Chang, Maha Karnoub, et al.
The Journal of Infectious Diseases|April 29, 2017
Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging CoronavirusesAnindya Siddharta, Stephanie Pfaender, Nathalie Jane Vielle, et al.
Respiratory Medicine|May 19, 2021
Clinical outcomes and quality of life of COVID-19 survivors: A follow-up of 3 months post hospital dischargeBeatriz Costa Todt, Claudia Szlejf, Etienne Duim, et al.
Journal of Hepatology|January 27, 2022
Hepatitis E virus is highly resistant to alcohol-based disinfectantsPatrick Behrendt, Martina Friesland, Jan-Erik Wißmann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 23, 2024
MicroRNAs modulate SARS-CoV-2 infection of primary human hepatocytes by regulating the entry factors ACE2 and TMPRSS2Rajendra Khanal, Natalie Heinen, Alexandra Bogomolova, et al.
Pageof 69